BioMaTek ApS: Financial statements 2023
CVR: 38928864
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BioMaTek ApS (CVR 38928864) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 271,486 and a net result of DKK 46,324 compared with DKK -118,048 the year before. That is an increase of 169% compared with the year before. Equity in the 2023 report amounted to DKK 108,646. The solvency ratio was 16.6%.
- Gross Profit
- DKK 271,486
- Profit/Loss
- DKK 46,324
- Equity
- DKK 108,646
- Total Assets
- DKK 655,457
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 271 t. | 46 t. | 109 t. | 0 |
| 2022 | - | 101 t. | -118 t. | 62 t. | - |
| 2021 | - | 245 t. | -7 t. | 180 t. | - |
| 2020 | - | 368 t. | 48 t. | 188 t. | - |
| 2019 | - | 51 t. | -13 t. | 139 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout BioMaTek ApS
BioMaTek ApS is a Danish company of the type Anpartsselskab based in Bedsted Thy, founded in 2017. The company is in liquidation. The company is registered under the industry Installation af isolering. The management consists of Jacob Morten Schousgaard. The company is owned by K.Y.M. ApS, TVT Group ApS and HN2024 Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 305,673 and a net result of DKK 6,138. Equity in the 2025 report amounted to DKK 18,905.